// App-Quantinova.ai

POS05 : Twelve-month outcomes with bioresorbable vascular scaffolds in real world coronary disease

Researchers

Presenter

  • Robaei D

Principal Investigators

  • Back L

  • Ooi S-Y

  • Pitney M

  • Jepson N

Medical Centers

  • Sutherland Hospital, Syndey, NSW, Australia

  • Prince of Wales Hospital, Sydney, Australia

Locations

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Myocardial infarction

  • Diabetes

  • Venous thrombosis

  • Restenosis

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Ticagrelor

  • Prasugrel

  • Aspirin

  • Albyl-E

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved